Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T.
Friedman HS, et al. Among authors: mikkelsen t.
J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31.
J Clin Oncol. 2009.
PMID: 19720927
Clinical Trial.